Health ❯Obesity ❯Treatment Options

Medications

GLP-1 Drugs Wegovy Clinical Research Compounding Pharmacies Semaglutide and Tirzepatide Self-Pay Pharmacy Semaglutide

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

The pharmaceutical giant shifts focus to early-stage obesity treatments following the latest setback in its weight-loss drug pipeline.

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

GLP-1 Drugs Revolutionize Obesity Treatment While Raising Questions About Risks and Costs

Doctors Question Safety and Efficacy of GLP-1 Supplements and Drugs for Weight Loss